tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks Names Kristin Stafford as New Chief Financial Officer
Company AnnouncementsZymeworks Names Kristin Stafford as New Chief Financial Officer
2d ago
ZYME
Zymeworks appoints Kristin Stafford as CFO
PremiumThe Fly
Zymeworks appoints Kristin Stafford as CFO
2d ago
NVCR
ZYME
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
PremiumRatings
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
3d ago
ZYME
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
PremiumCompany Announcements
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
4d ago
ZYME
Zymeworks receives FDA Fast Track Designation for ZW191
PremiumThe Fly
Zymeworks receives FDA Fast Track Designation for ZW191
4d ago
ZYME
Zymeworks announces Fast Track designation for ZW191 by FDA
PremiumThe FlyZymeworks announces Fast Track designation for ZW191 by FDA
4d ago
ZYME
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
Premium
Company Announcements
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
10d ago
ZYME
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
Premium
Company Announcements
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
15d ago
ZYME
Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting
PremiumThe Fly
Zymework’ partner Jazz to present on Ziihera at 2026 AACR Annual Meeting
16d ago
JAZZ
ZYME
Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting
PremiumCompany Announcements
Zymeworks Highlights ADC and Novel Pan-RAS Platform Data Ahead of AACR Meeting
16d ago
ZYME
Zymeworks price target raised to $48 from $33 at Evercore ISI
PremiumThe Fly
Zymeworks price target raised to $48 from $33 at Evercore ISI
25d ago
RPRX
ZYME
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
PremiumCompany Announcements
Zymeworks Earnings Call: Zanidatumab Drives Bullish Outlook
25d ago
ZYME
Zymeworks price target raised to $46 from $32 at H.C. Wainwright
PremiumThe FlyZymeworks price target raised to $46 from $32 at H.C. Wainwright
28d ago
ZYME
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
Premium
Ratings
Zymeworks: Strengthened Liquidity and Preserved Zanidatamab Royalty Upside Support Overweight Rating
1M ago
ZYME
Zymeworks price target raised to $47 from $40 at Stifel
Premium
The Fly
Zymeworks price target raised to $47 from $40 at Stifel
1M ago
ZYME
Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
PremiumCompany Announcements
Zymeworks’ Growth Clouded by High Clinical Failure Risk and Regulatory Uncertainty
1M ago
ZYME
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
PremiumThe Fly
Morning Movers: Travel stocks fall following U.S.-Israeli strikes on Iran
1M ago
AAL
COP
Zymeworks Monetizes Ziihera Royalties to Boost Liquidity
PremiumCompany Announcements
Zymeworks Monetizes Ziihera Royalties to Boost Liquidity
1M ago
8K
ZYME
Zymeworks Posts Strong 2025 Growth and Bolsters Liquidity
PremiumCompany Announcements
Zymeworks Posts Strong 2025 Growth and Bolsters Liquidity
1M ago
8K
ZYME
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
PremiumThe FlyZymeworks, Royalty Pharma enter $250M royalty-backed note financing
1M ago
ONC
JAZZ
Zymeworks reports Q4 EPS (55c) vs. (31c) last year
Premium
The Fly
Zymeworks reports Q4 EPS (55c) vs. (31c) last year
1M ago
ZYME
ZYME Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
ZYME Upcoming Earnings Report: What to Expect?
1M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >